$9 Mln
$47 Mln
1.16
As on 27-Sep-2023 16:00 EDT
$-0.01
•
-1.39%
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|
|---|---|---|---|---|---|---|---|
|
Catalyst Biosciences (CBIO)
| 51.98 | -23.43 | 60.06 | 67.01 | -43.57 | -40.36 | -46.49 |
|
S&P BSE Sensex*
| 7.85 | 1.12 | 3.47 | 14.90 | 20.62 | 12.55 | 12.77 |
|
#
| -- | -- | -- | -- | -- | -- | -- |
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|
|---|---|---|---|---|---|---|---|
|
Catalyst Biosciences (CBIO)
| 121.49 | -85.58 | -7.34 | -13.69 | -41.98 | 39.88 | -79.23 |
|
S&P BSE Sensex
| 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 | 1.95 |
|
S&P BSE Sensex
| 4.44 | 21.99 | 15.75 | 14.38 | 5.87 | 27.91 | 1.95 |
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
|
Stock
|
Peer Median
|
||
|---|---|---|---|
Please wait... |
|||
The total asset value of Catalyst Biosciences Inc. (CBIO) stood at $ 26 Mln as on 31-Mar-23
The share price of Catalyst Biosciences Inc. (CBIO) is $0.496200 (NASDAQ) as of 27-Sep-2023 16:00 EDT. Catalyst Biosciences Inc. (CBIO) has given a return of -43.57% in the last 3 years.
Catalyst Biosciences Inc. (CBIO) has a market capitalisation of $ 9 Mln as on 02-Jun-2023. As per Value Research classification, it is a company.
The P/B ratio of Catalyst Biosciences Inc. (CBIO) is 0.53 times as on 02-Jun-2023, a -0.79% premium to its peers’ median range of 2.54 times.
The P/E (price to earnings) ratio of Catalyst Biosciences Inc. (CBIO) is 1.16 times as on 02-Jun-2023.
Step 1. Open a demat account through a broker. You would need to provide your email, PAN, bank account details, aadhar details, etc., for KYC
Step 2. Sign in to the broker’s application through a mobile app or website. Use the Login ID and password provided by your broker.
Step 3. Transfer funds from your bank account into the wallet present in your brokerage account.
Step 4. Search for the Catalyst Biosciences Inc. (CBIO) and enter the required number of quantities and click on buy to purchase the shares of Catalyst Biosciences Inc. (CBIO).
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California.
The CEO & director of Dr. Nassim Usman Ph.D.. is Catalyst Biosciences Inc. (CBIO), and CFO & Sr. VP is Ms. Seline E. Miller CPA.
The promoters of Catalyst Biosciences Inc. (CBIO) have pledged 0% of the total equity as on Mar-23.
Some of the close peers are:
| Company | Market Cap($ Mln) |
|---|---|
|
313
|
|
|
286
|
|
|
34
|
|
|
12
|
| Catalyst Biosciences Inc. (CBIO) | Ratios |
|---|---|
|
Return on equity(%)
|
--
|
|
Return on capital employed(%)
|
--
|
|
Debt-to-equity ratio
|
0
|
|
Dividend yield(%)
|
0
|
Yes, TTM profit after tax of Catalyst Biosciences Inc. (CBIO) was $47 Mln.
$8.72 Mln
$-0.79 Mln
$46.75 Mln
$8.10 Mln
$0.00 Mln
High
$0.19 - 0.74
37,759,800
NASDAQ: CBIO
South San Francisco, CA
https://www.catalystbiosciences.com
Catalyst Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of liver fibrosis associated with a broad spectrum of chronic liver diseases in the United States and internationally. It develops... Hydronidone, that has completed phase 1 clinical trial for the treatment of nonalcoholic steatohepatitis, a severe form of nonalcoholic fatty liver disease. The company was founded in 2002 and is headquartered in South San Francisco, California. Read more
Learn the principles, mindset and tools you need to become a successful Mutual Fund and Stock investor from the masters who have been doing this for decades.
Use India's most advanced investment tracker to track, analyse and get updates and insights on your investments.
Get an analysis of your portfolio along with actionable, general tips and insights, guidance on where to invest based on your goals, and experts' opinions on individual Mutual Funds and Stocks.
Value Research offers the most advanced and detailed data & analytics available on Mutual Funds and Stocks. Sign up and unlock the power yourself.
Unlimited access to advice from India's top experts
The most comprehensive analysis of funds and stocks in India
A holistic portfolio manager to help track all your investments easily
And much more, like guides, tools, webinars, videos and eBooks.
Share via Facebook 
Share via Twitter 
Share via LinkedIn 
Share this
